ATE275577T1 - Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung - Google Patents

Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung

Info

Publication number
ATE275577T1
ATE275577T1 AT99957805T AT99957805T ATE275577T1 AT E275577 T1 ATE275577 T1 AT E275577T1 AT 99957805 T AT99957805 T AT 99957805T AT 99957805 T AT99957805 T AT 99957805T AT E275577 T1 ATE275577 T1 AT E275577T1
Authority
AT
Austria
Prior art keywords
composition containing
pharmaceutically active
active composition
quinapril
magnesium
Prior art date
Application number
AT99957805T
Other languages
English (en)
Inventor
Bernard Charles Sherman
Original Assignee
Bernard Charles Sherman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19927062&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE275577(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bernard Charles Sherman filed Critical Bernard Charles Sherman
Application granted granted Critical
Publication of ATE275577T1 publication Critical patent/ATE275577T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99957805T 1998-12-08 1999-12-07 Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung ATE275577T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ333206A NZ333206A (en) 1998-12-08 1998-12-08 Solid pharmaceutical compositions comprising a stable magnesium salt of quinapril that acts as a ACE (Angiotensin Converting Enzyme) inhibitor
PCT/CA1999/001169 WO2000034314A1 (en) 1998-12-08 1999-12-07 Pharmaceutical compositions comprising quinapril magnesium

Publications (1)

Publication Number Publication Date
ATE275577T1 true ATE275577T1 (de) 2004-09-15

Family

ID=19927062

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99957805T ATE275577T1 (de) 1998-12-08 1999-12-07 Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung

Country Status (15)

Country Link
US (1) US6531486B1 (de)
EP (1) EP1137662B1 (de)
JP (1) JP5296277B2 (de)
KR (1) KR20010080718A (de)
AT (1) ATE275577T1 (de)
AU (1) AU759889B2 (de)
BR (1) BR9916021A (de)
CA (1) CA2355347C (de)
CZ (1) CZ20012013A3 (de)
DE (1) DE69920039T2 (de)
ES (1) ES2229793T3 (de)
IL (1) IL143652A0 (de)
NZ (1) NZ333206A (de)
WO (1) WO2000034314A1 (de)
ZA (1) ZA200104614B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ508544A (en) * 1998-06-05 2002-10-25 Warner Lambert Co Angiotensin converting enzyme inhibitors, such as quinapril, enalapril and indolapril, stabilised with 1-90 wt% magnesium oxide
US20030027837A1 (en) * 1998-12-08 2003-02-06 Sherman Bernard Charles Pharmaceutical compositions comprising quinapril magnesium
CA2357982A1 (en) * 2001-09-28 2003-03-28 Bernard Charles Sherman Solid compositions comprising ramipril
AU2003270245A1 (en) * 2003-09-23 2005-04-11 Texcontor Etablissement Stable quinapril compositions
GB201017808D0 (en) 2010-10-21 2010-12-01 Univ Salford The An air spring
GB201405647D0 (en) 2014-03-28 2014-05-14 Carbon Air Ltd Transfer method and apparatus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4830853A (en) 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
US4761479A (en) * 1987-03-30 1988-08-02 Warner-Lambert Company Crystalline quinapril and a process for producing the same
YU48602B (sh) 1991-11-25 1998-12-23 Krka Tovarna Zdravil P.O. Postupak za dobijanje stabilne formulacije soli enalaprila
US5573780A (en) 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof
NZ508544A (en) * 1998-06-05 2002-10-25 Warner Lambert Co Angiotensin converting enzyme inhibitors, such as quinapril, enalapril and indolapril, stabilised with 1-90 wt% magnesium oxide

Also Published As

Publication number Publication date
EP1137662B1 (de) 2004-09-08
KR20010080718A (ko) 2001-08-22
CA2355347C (en) 2011-06-21
WO2000034314A1 (en) 2000-06-15
ZA200104614B (en) 2002-06-26
CZ20012013A3 (cs) 2001-10-17
DE69920039T2 (de) 2005-09-22
ES2229793T3 (es) 2005-04-16
IL143652A0 (en) 2002-04-21
JP2002531577A (ja) 2002-09-24
NZ333206A (en) 2000-07-28
BR9916021A (pt) 2001-10-30
CA2355347A1 (en) 2000-06-15
EP1137662A1 (de) 2001-10-04
AU1542200A (en) 2000-06-26
DE69920039D1 (de) 2004-10-14
JP5296277B2 (ja) 2013-09-25
AU759889B2 (en) 2003-05-01
US6531486B1 (en) 2003-03-11

Similar Documents

Publication Publication Date Title
YU23599A (sh) Stabilizovani antihistaminski sirup
RS52214B (en) HDAC INHIBITOR PHARMACEUTICAL FORMULATIONS
EP1340755A4 (de) Mittel mit wirkung gegen helicobacter
CA2327723A1 (en) Bicyclic hydroxamic acid derivatives
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
CA2504797A1 (en) Base for oral composition and the oral composition
FI935380A0 (fi) Laekemedel innehaollande S(+)-ibuprofen
CA2338896A1 (en) Fast dissolving ibuprofen containing compositions having analgesic activity
WO2004017998A3 (en) Topical emulsion- gel composition comprising diclofenac sodium
YU17301A (sh) KRISTALNI OBLICI EtO2C-CH2-(R)-Cgl-Aze-Pab-OH
TR200003688T1 (tr) Glutation'un absorbsıyonu'nun arttırılması ve etkilerinin güçlendirilmesi için kompozisyon
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
DE60236025D1 (de) Pharmazeutische zusammensetzung enthaltend l-arginin
ATE275577T1 (de) Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung
EA200100947A1 (ru) Жевательные таблетки с высоким содержанием n-ацетилцистеина
GB0212410D0 (en) Organic compounds
EP1142878A3 (de) Moexipril-Magnesium enthaltende Arzneimittel
WO2002011740A3 (en) 'slow release' pharmaceutical compositions comprising lithium carbonate
EA200000772A1 (ru) Фармацевтические композиции и способы их приготовления
FR2393578A1 (fr) Composition antibacterienne a base d'acide 6-(d(-)-a-(4-ethyl-2,3-dioxo-1-piperazinylcarbonylamino)phenylacetamido) penicillanique
IT1302289B1 (it) Composizioni farmaceutiche ad attivita' antineoplastica
IE38940L (en) Pharmaceutical compositions; salts of p-chlorohippuric acid
ECSP045086A (es) Composiciones farmaceuticas que contienen macrolidos
RU2000118069A (ru) Добавка в бетонную смесь
EA200400954A1 (ru) Фармацевтическая композиция, содержащая 2,2-дихлор-12-(4-хлорфенил)додекановую кислоту

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties